Pfizer Inc. (NYSE:PFE) share price jumped at US$ 33.89 before falling back to end the trade at US$ 33.62 a share. The dividend stock is -7.5% off a 52-week high stock price of US$ 37.39 but is up 21.42% since hitting the US$ 28.74. Investors are buying the stock with a trailing-twelve-month price-to-earnings (P/E) ratio of 33.55.
After a 0% fall from previous close of US$ 33.62, Pfizer Inc. (PFE) has a US$ 204.02 Billion market cap. The company pays a US$ 0.32-cent-per-share quarterly dividend, giving it a 3.81% yield. That brings its full year payout to US$ 1.28 and 102.5% annual payout ratio based on EPS. According to FT, Year on year, growth in dividends per share increased 7.69% while earnings per share excluding extraordinary items fell by -21.49%. The positive trend in dividend payments is noteworthy since very few companies in the Major Drugs industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth ranked highest relative to its industry peers, while earnings per share growth is in-line with the industry average.
The PFE has soared 4.56% year-to-date. The equity has gained steam in recent weeks, with shares up about 6.27% in the past three months. It added 3.93%, climbed 7.14% and jumped -2.53% in the week, one month and six months, respectively. Revenue growth rate was recorded at 0% and net income per share was seen moving at a 1.32% rate in the past five years.
Pfizer Inc. (NYSE:PFE) is over 9% above analysts’ consensus price target of US$ 37.48. The stock has blown through analysts’ low price target of US$ 33, but is still below the high US$ 52 target. On a price appreciation basis over the past 12 months, the stock returned 18.33%.
Financial Times data shows, Historical dividend information is not available for Pfizer Inc. The most recent short interest data show 0.57% of the company’s stock are short sold. It would take about 1.36 days to cover all short positions. In terms of volatility, it has a beta coefficient of 0.98 and technical analysis volatility indicator called Average True Range or ATR around 0.49.
Pfizer Inc. (NYSE:PFE) closed 1.96% above its 200-day moving average which many technicians use as a guide to the long-term trend, so stocks above the line are considered to be in longer-term uptrends, while those below it are considered to be in downtrends. The stock is 4.8% above another chart threshold, its 50-day moving average and 5.39% above its 20-day simple moving average.Dividend Stock To Monitor: Pfizer Inc. (PFE)